Views: 0 Author: Site Editor Publish Time: 2025-05-06 Origin: Site
In 2025, Hangzhou Sunrise Medical Co., Ltd. proudly enters a new phase of development, driven by innovation, international expansion, and increased production capacity. With a decade-long commitment to excellence in medical aesthetics and wound care manufacturing, our factory has undergone a strategic upgrade — both in technology and global positioning.
This new chapter is marked by:
The launch of next-generation production lines for injectable packaging systems
Expanded cleanroom facilities and enhanced GMP-compliant processes
Strengthened R&D capabilities to support customized OEM/ODM solutions
A broader global presence across Europe, the Middle East, and South America
As we continue to meet international standards like FDA, ISO 13485, and ISO/IEC 17025, Sunrise Medical remains committed to delivering trusted quality, scalable solutions, and long-term value to partners around the world.
2025 marks not only a milestone year but a transformation in how we serve the evolving needs of the global medical market.
We invite strategic partners to grow with us in this new era.
